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Pathological classifications in current use for the assessment of
glomerular disease have been typically opinion-based and built
on the expert assumptions of renal pathologists about lesions
historically thought to be relevant to prognosis. Here we
develop a unique approach for the pathological classification of
a glomerular disease, IgA nephropathy, in which renal
pathologists first undertook extensive iterative work to define
pathologic variables with acceptable inter-observer
reproducibility. Where groups of such features closely
correlated, variables were further selected on the basis of least
susceptibility to sampling error and ease of scoring in routine
practice. This process identified six pathologic variables that
could then be used to interrogate prognostic significance
independent of the clinical data in IgA nephropathy (described
in the accompanying article). These variables were (1) mesangial
cellularity score; percentage of glomeruli showing (2) segmental
sclerosis, (3) endocapillary hypercellularity, or (4) cellular/
fibrocellular crescents; (5) percentage of interstitial fibrosis/
tubular atrophy; and finally (6) arteriosclerosis score. Results for
interobserver reproducibility of individual pathological features
are likely applicable to other glomerulonephritides, but it is not
known if the correlations between variables depend on the
specific type of glomerular pathobiology. Variables identified in
this study withstood rigorous pathology review and statistical
testing and we recommend that they become a necessary part
of pathology reports for IgA nephropathy. Our methodology,
translating a strong evidence-based dataset into a working
format, is a model for developing classifications of other types
of renal disease.
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The histological diagnosis of IgA nephropathy is straightfor-
ward; it is defined by the presence of IgA-dominant or co-
dominant immune deposits within glomeruli, as shown by
immunohistochemistry or immunofluorescence. However,
biopsies meeting this criterion may show a wide range of
histological changes that reflect the clinical diversity of IgA
nephropathy. Biopsy appearances may range from virtually
normal histology by light microscopy to severe necrotizing,
crescentic glomerulonephritis or advanced glomerulosclero-
sis, and tubular atrophy. There have been numerous
clinicopathological studies of IgA nephropathy, the great
majority being retrospective, correlating histological changes
in diagnostic biopsy with clinical outcome. A number of
histological lesions have been reported to be of prognostic
value (Table 1).1–15 The apparently conflicting results of these
studies reflect differences in patient cohort, treatment, and
clinical outcome measures. In general, studies in which the
clinical end point is time to dialysis/renal failure have shown
that chronic lesions (tubular atrophy, interstitial fibrosis, and
glomerulosclerosis) are the most powerful histological
predictors of outcome. This is not surprising, as these lesions
reflect an advanced stage of disease; those patients who are
biopsied and diagnosed late in the course of their disease will
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have a shorter time to end-stage renal disease. In contrast,
those studies that have correlated histological changes with rate
of loss of renal function or response to immunosuppressive
therapy have shown that active glomerular lesions (mesangial,
endocapillary or extracapillary proliferation, necrosis) are the
most significant pathological prognostic factors.
There have been a number of attempts to incorporate the
various histological lesions into a pathological classification
of IgA nephropathy. None has achieved widespread accep-
tance. Deficiencies include a lack of definitions and use
of vague terminology, lack of an evidence base, and inclusion
of both active and chronic lesions in the definition of
single categories. For example, a recent classification divides
biopsies into four categories (I–IV), namely, no,
slight (o10%), moderate (10–30%), and severe (430%)
glomerulosclerosis, crescent formation, or adhesion.16 Although
such a schema may accurately identify those patients who
will develop renal failure, it cannot be used to guide
patient management; clearly, the management of patients with
class IV disease due to 430% glomerular crescents will
differ from those with class IV disease due to diffuse
glomerulosclerosis.
As described in the accompanying paper17, we sought to
develop an international consensus classification of IgA
nephropathy with a strong evidence base. In this paper, we
describe in detail the process by which histological data were
collected and reviewed, and present the evidence used for
selecting those pathological lesions that were included
in the final schema (the ‘Oxford Classification’ of IgA
Nephropathy). The overall philosophy was to collect a highly
detailed initial pathological data set and to simplify this
into a working schema. We recognize that a ‘successful’
classification must have clear definitions, be simple to use in
routine clinical practice, be reproducible, and have a value
independent of the clinical parameters at the time of biopsy.
These criteria, therefore, formed the basis of our selection of
which lesions to include in the final classification.
RESULTS
Pathology definitions
An initial meeting of pathologists was held in Oxford, UK, in
2005 to define the pathological variables to be assessed in
renal biopsies in cases of IgA nephropathy. After a provisional
analysis of the first 40 cases, areas of high interobserver
variation were identified. To improve reproducibility, the
definitions were refined at a meeting of pathologists in
Atlanta, USA, in 2006 (Table 2). These were subsequently
used for histological scoring of the entire study group. A
minor amendment (in italics in Table 2) for defining necrosis
in routine practice was agreed upon at a further meeting in
Oxford in 2008.
Scoring of histological lesions
A detailed pathology data set was collected initially, with the
intention of working to simplify it for use in routine practice.
Histology slides from each case were circulated among five
pathologists in batches of five, in a rolling manner, to
ensure that no two batches were scored by the same five
pathologists. A score sheet was completed by individual
pathologists for each biopsy (Table 3) using an agreed set of
instructions (Table 4). Scoring of mesangial cellularity,
together with other proliferative and sclerosing glomerular
lesions, is illustrated in Figures 1 and 2. Completed score
sheets were collected centrally by one of the pathologists
(ISDR) and used to compile the extended pathological data
set (Table 5). Completed score sheets were received from five
pathologists for 47% of the cases, from four pathologists
for 36% of the cases, and from three pathologists for 17% of
the cases.
Extended pathology data set
For most histological variables, the median score was taken
for analysis (Table 5).
For scoring of glomerular crescents, the mean cellular and
fibrocellular crescent scores were obtained by weighing the
Table 1 | Histological risk factors for progressive renal failure in IgA nephropathy
Reference
Mesangial
cellularity
Endocapillary
proliferation Crescents
Capillary
wall IgA
Focal
segmental
sclerosis Glomerulosclerosis
Interstitial
fibrosis/tubular
atrophy
Nozawa et al.1 X
Ballardie et al.2 X
To et al.3 X
Mera et al.4 X
Daniel et al.5 X
Vleming et al.6 X
Freese et al.7 X X X
Hogg et al.8 X X
Katafuchi et al.9 X X
Ibels et al.10 X X
Okada et al.11 X X
Bogenschutz et al.12 X
Rekola et al.13 X
D’Amico et al.14 X X X
Boyce et al.15 X
X, statistically significant association with clinical outcome.
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Table 2 | Pathological definitions
IgA nephropathy: IgA nephropathy in the native kidney is defined as dominant or codominant staining with IgA in glomeruli by immunofluorescence or
immunoperoxidase. Not all glomeruli need show this positivity. SLE-related nephritis should be excluded. The intensity of IgA staining should be more
than trace. The distribution of IgA staining should include presence in the mesangium, with or without capillary loop staining, excluding a pure
membranous, diffuse, global granular GBM staining pattern or a linear GBM staining pattern. IgG and IgM may be present, but not in greater intensity
than IgA, except that IgM may be prominent in sclerotic areas. Complement 3 (C3) may be present. The presence of C1q staining in more than trace
intensity should bring up consideration of lupus nephritis.
Glomerular definitions
Diffuse: A lesion involving most (X50%) glomeruli
Focal: A lesion involving o50% of glomeruli
Global: A lesion involving more than half of the glomerular tuft (See below for definitions of segmental and global sclerosis)
Segmental: A lesion involving less than half of the glomerular tuft (i.e., at least half of the glomerular tuft is spared). See below for definitions of
segmental and global sclerosis
Endocapillary hypercellularity: Hypercellularity due to increased number of cells within glomerular capillary lumina, causing narrowing of the lumina
Karyorrhexis: Presence of apoptotic, pyknotic, and fragmented nuclei
Necrosis is defined by (i) disruption of the glomerular basement membrane with (ii) fibrin exudation and (iii) karyorrhexis. At least two of these three
lesions need to be present to meet the criteria for necrosis. (2008 Amendment: Necrosis should not be scored on the PAS-stained section alone; fibrin is more
easily identified on H&E or MSB-stained sections, and breaks in the glomerular basement membrane are more easily identified on silver-stained sections. A
minimum requirement for the definition of a necrotizing lesion is extracapillary fibrin exudation.)
GBM duplication: A double contour of the GBM with or without endocapillary hypercellularity
Increased mesangial matrix: An increase in the extracellular material in the mesangium such that the width of the interspace exceeds two mesangial
cell nuclei in at least two glomerular lobules
Sclerosis: Obliteration of the capillary lumen by increased extracellular matrix, with or without hyalinosis or foam cells
An adhesion: An area of continuity between the glomerular tuft and Bowman’s capsule separate from an extracapillary lesion or from an area of
segmental sclerosis
Segmental sclerosis: Any amount of the tuft involved with sclerosis, but not involving the whole tuft
Global sclerosis: The entire glomerular tuft involved with sclerosis
Collapsed/ischemic glomerulus: A glomerulus showing collapse of the capillary tuft with or without thickening of Bowman’s capsule and fibrosis in the
Bowman’s space
Extracapillary lesions are subclassified as follows:
Extracapillary proliferation or cellular crescent: Extracapillary cell proliferation of more than two cell layers with450% of the lesion occupied by cells. It
is further classified by the percentage of glomerular circumference involved: o10, 10–25, 26–50, and 450%
Extracapillary fibrocellular proliferation or fibrocellular crescent: An extracapillary lesion comprising cells and extracellular matrix, with o50% cells and
o90% matrix. This is further classified by the percentage of the glomerular circumference involved: o10, 10–25, 26–50, and 450%
Extracapillary fibrosis or fibrous crescent:410% of the circumference of Bowman’s capsule covered by a lesion composed ofX90% matrix. It is further
classified by the percentage of the glomerular circumference involved: 10–25%, 26–50%, and450%. Ischemic, obsolescent glomeruli should be excluded
A crescent is one of these extracapillary lesions that involves 410% of the circumference of Bowman’s capsule
Mesangial hypercellularity is subclassified as follows:
If o4 mesangial cells/mesangial area=normal,
4–5 mesangial cells/mesangial area=mild mesangial hypercellularity,
6–7 mesangial cells/mesangial area=moderate mesangial hypercellularity, and
8 or more mesangial cells/mesangial area=severe mesangial hypercellularity.
Note: This is scored for each glomerulus by assessing the most cellular mesangial area. Mesangial areas immediately adjacent to the vascular stalk should
not be scored. Individual mesangial areas showing hypercellularity are separated by areas narrowing to the width ofo2 mesangial cell nuclei (i.e., count
clusters, not files of mesangial cell nuclei)
Tubulointerstitial definitions
Tubular atrophy is defined by thick irregular tubular basement membranes with decreased diameter of tubules. It is scored according to the
percentage of cortical area involvement, with 1–5% rounded to 5% and other values rounded to the closest 10%
Interstitial fibrosis is defined as increased extracellular matrix separating tubules in the cortical area. It is scored as percentage involvement, with 1–5%
rounded to 5% and other values rounded to the closest 10%.
Interstitial inflammation is defined as inflammatory cells within the cortical interstitium in excess. It is scored as percentage involvement, with 1–5%
rounded to 5% and other values rounded to the closest 10%. It should be noted whether the inflammation is confined to the areas of interstitial fibrosis
or not
Additional tubular lesions are noted as follows: The presence of numerous red blood cells, defined as tubules completely filled with red blood cells with
or without casts, is noted as a lesion when it involves X20% of tubules
Acute tubular injury of the proximal tubular epithelium is defined by simplification of the epithelium without tubular basement membrane thickening
Vascular definitions
Arterial lesions are scored based on the most severe lesions. Interlobular and larger arteries are scored separately. An interlobular artery is one
surrounded by the cortex; an arcuate artery is one at the corticomedullary junction. Intimal thickening is scored by comparing the thickness of the intima
to that of the media in the same segment of vessel. Score the intima variously as normal, and thickened to more or less than the thickness of the media.
Arteriolar hyaline is noted as the proportion of arterioles affected (0, 1–25%, 26–50%, 450%).
GBM, glomerular basement membrane; H&E, hematoxylin and eosin stain; MSB, Martius scarlet blue; PAS, periodic acid Schiff; SLE, systemic lupus erythematosus.
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extracapillary lesions by size. A multiplication factor of 1 was
applied for lesionso10% of the glomerular circumference, 2
for lesions 10–25% of the glomerular circumference, 3 for
lesions 26–50% of the glomerular circumference, and 4 for
lesions450% of the glomerular circumference. The resulting
scores were summed and divided by the total number of
glomeruli in the biopsy.
Additional data items were derived from the completed
score sheets to address specific questions. For example,
Mesangial 1 versus 2: Is the proportion of severely
hypercellular glomeruli of different significance than that of
the mean mesangial cellularity?
Extracapillary 1 versus 2: Are cellular and fibrocellular
crescents of different significances?
Table 3 | Score sheet used for collecting detailed histological data set
Table 4 | Guidelines for completion of the light microscopy score sheet
1. Using the circled PAS-stained section: for every glomerulus, mark one box only in Column A. If the indeterminate for mesangial cellularity box is
marked, then mark which of the five reasons for not scoring mesangial cellularity applies. At least three mesangial cell areas should be present to score
a glomerulus. In the global sclerosis category include both solidified and obsolescent glomeruli, and advanced segmental sclerosis when o3
mesangial areas remain. Mesangial cellularity is difficult to score in segments showing endocapillary hypercellularity. Therefore, glomeruli showing
global endocapillary hypercellularity should be classed as indeterminate for mesangial cellularity (and the endocapillary lesions noted in column B).
Score each glomerulus by assessing the most cellular mesangial area. Mesangial areas immediately adjacent to the vascular stalk should not be scored.
Individual mesangial areas showing hypercellularity are separated by areas of narrowing to the width ofo2 mesangial cell nuclei (i.e., count clusters,
not files, of mesangial cell nuclei). Mesangial cell nuclei are those surrounded by the matrix; do not count those projecting into a capillary lumen
2. Using the circled PAS-stained section: for every glomerulus, mark none, one, or more than one box in Column B as appropriate
A segmental lesion with capillary occlusion by both sclerosis and endocapillary hypercellularity should be scored for both. Endocapillary
hypercellularity is defined by the presence of cells within capillary lumina, not by the matrix. Therefore, in the presence of segmental sclerosis,
endocapillary hypercellularity can only be scored within that segment if preserved capillary loops are also present
GBM duplication: score if it involves an open capillary loop but not as part of a sclerosed segment
3. Using any of the provided sections: for the whole biopsy, mark any box in Column C that applies
When noting excessive mesangial matrix increase, assess only mesangial areas away from segmental sclerosis, i.e., associated with patent capillary
loops
For scoring arteriolar hyalinosis in Column C, examine only the PAS-stained section used for glomerular scoring
4. In the ‘Other’ box: note any other abnormality seen, e.g., a glomerular lesion present in one of the sections but not represented in the PAS section
used for scoring, mesangiolysis, large numbers of RBC casts, ATN, and malignant vascular disease. Sections should be 2–3 mm thick for scoring. Note if
the section appears thicker
5. Total number of glomeruli=total scorable glomeruli+total indeterminate for mesangial cellularity. To produce the mesangial score, multiply the totals
of the boxes in column A by 0, 1, 2, or 3 as appropriate. The mean mesangial score is the total of the mesangial scores divided by the number of
scorable glomeruli
ATN, acute tubular necrosis; GBM, glomerular basement membrane; PAS, periodic acid Schiff; RBC, red blood cell.
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Extracapillary 2 versus 3: Is the size of a crescent
significant?
Interstitial inflammation 1 versus 2: Is inflammation
confined to areas of fibrosis of different significance compared
with inflammation also involving non-fibrotic cortex?
Arteriole 1 versus 2: Is the extent of arteriolar hyalinosis,
rather than merely its presence or absence, of significance?
The final, simplified set of pathological variables was
selected on the basis of independence from other histological
lesions, simplicity of assessment, and reproducibility.
Reproducibility of pathology variables
During the development process, considerable effort was
made to minimize interobserver variation between patholo-
gists in the working group. It was agreed that histological
lesions that continued to show poor reproducibility within
this group should not be a part of the final classification, as
the reproducibility is likely to be even lower among
pathologists in routine clinical practice. Reproducibility was
assessed statistically using intraclass correlation coefficients
(ICCs), which are summarized in Table 5.
On the basis of the ICC scores, lesions were divided into
three groups as follows:
Group 1: Those lesions showing good or very good
reproducibility (40.6) were mesangial cellularity score,
percentage of global glomerulosclerosis, percentage of
cellularþ fibrocellular crescents, cellularþ fibrocellular
crescent score (including adjustment for size of crescent),
tubular atrophy, interstitial fibrosis, interstitial inflammation
1, and arterial scores 1, 2, and 3.
Group 2: Those lesions showing moderate reproducibility
(0.4–0.6) were extent of segmental glomerulosclerosis and
percentage of glomeruli showing either segmental or global
endocapillary hypercellularity.
Group 3: Those lesions showing poor or fair reproduci-
bility (o0.4) were percentage of normal glomeruli, presence
of adhesions, percentage of glomeruli showing segmental
endocapillary hypercellularity, presence of glomerular base-
ment membrane duplication, presence of necrosis, percentage
of glomeruli showing fibrous crescents, interstitial inflamma-
tion 2 (inflammation involving non-fibrotic cortex), and
arteriolar hyalinosis.
Those lesions in group 3 were excluded from the
classification on the basis of poor reproducibility, with the
exception of the following:
K Adhesions: Reproducibility increased when combined
with segmental sclerosis, indicating that the low ICC
score for adhesions alone resulted from different
a b
c d
e f
*
Figure 2 |Proliferative and sclerosing glomerular lesions. All
figures objective 40 original magnification, periodic acid Schiff
stain. (a) Normal glomerulus by light microscopy. (b) Tuft
adhesion (arrow) without segmental sclerosis. This lesion should
be included with segmental sclerosis lesions for scoring purposes.
(c) Segmental sclerosis (arrow) with a lobule away from the
sclerosis showing moderate mesangial hypercellularity
(arrowhead). (d) Extensive segmental sclerosis (arrow). This
glomerulus should not be used for mesangial scoring. (e) A
glomerulus showing severe mesangial hypercellularity (arrow) and
a small cellular crescent (arrowhead; 10–25% of the glomerular
circumference). (f) A glomerulus showing mild mesangial
hypercellularity (arrow). There is segmental endocapillary
hypercellularity (arrowhead); this segment should not be used for
mesangial scoring. In addition, there is a cellular crescent (asterisk;
25–50% of the glomerular circumference).
A segment of endocapillary 
hypercellularity, showing 
intracapillary inflammatory
cells. This should not be used 
for scoring of mesangial 
cellularity.
A segment of moderate 
mesangial hypercellularity.
Clusters, not cords, of 
mesangial cell nuclei should 
be counted. The glomerulus 
is scored according to the 
most cellular lobule (nuclei 
highlighted in yellow).
Perihilar and central mesangial area that should not be
used for scoring mesangial cellularity.
Figure 1 |An illustration of mesangial cellularity scoring
(objective 40 original magnification, periodic acid Schiff
stain).
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pathologists labeling the same lesion as either segmental
sclerosis or an adhesion. For subsequent analysis,
segmental sclerosis and adhesions were summed.
K Necrosis: At the Oxford 2008 meeting, periodic acid schiff
(PAS)-stained sections and all other slides from cases in
which at least one pathologist had recorded the presence
of necrosis were reviewed independently by each of the
pathologists. The initial scoring, on which the ICC is
calculated, had been carried out on only a single circled
PAS-stained section. Reproducibility was higher when all
slides, rather than only the PAS-stained slide, were
examined (data not shown). This review led to a further
refinement of the definition of necrosis to increase
reproducibility (see Table 2).
K Endocapillary hypercellularity: The ICC for the sum of
percentage of segmental and global endocapillary hyper-
cellularity was considerably higher than that for the
percentage of segmental hypercellularity, indicating that
there was poor reproducibility for the distinction of
segmental from global lesions rather than for the
identification of endocapillary hypercellularity. The sum
of segmental and global endocapillary hypercellularity
was, therefore, used in subsequent analyses.
Correlation between pathology variables
Significant correlations between 23 pathology variables
(excluding ‘normal glomeruli’) are shown in Table 6. Given
the 253 different comparisons possible, the initial significance
was set at P¼ 0.05/253, that is, P¼ 0.0002. Seventy-seven
comparisons were considered statistically significant.
Several of the strong correlations are not unexpected; for
example, the correlations between interstitial fibrosis and
tubular atrophy and between both of these and global
glomerulosclerosis. However, there are other significant
correlations that may be important in terms of pathogenesis.
Thus, segmental sclerosis correlates with extracapillary
lesions including either fibrocellular or fibrous crescents,
suggesting a common pathogenesis. It is also of interest that
capillary wall duplication, although poorly reproducible,
does show a significant correlation with endocapillary
proliferation.
Although many of the pathology variables showed a
significant correlation with others, the correlation coefficient
between some was so close to 1 that to include both in a
classification would provide no additional value. For
example, the ‘R’ values for endocapillary 1 and 2 (0.99),
extracapillary 2 and 3 (0.99), interstitial fibrosis and tubular
atrophy (0.98), interstitial fibrosis and interstitial inflammation
(0.9), interstitial fibrosis and global glomerulosclerosis (0.8),
arterial 2 and 3 (0.9), and arteriole 1 and 2 (0.95) indicated
that these pairs of variables were very closely linked.
The selection of which of the linked variables to include in
the classification was based on reproducibility, ease of
identification, and susceptibility to sampling error. For
example, extracapillary 2, a simple calculation of %
cellularþ fibrocellular crescents, was preferred to extracapil-
lary 3, a complex calculation requiring scoring of the size of
the crescents in each glomerulus. Interstitial fibrosis and
tubular atrophy were preferred to global glomerulosclerosis,
Table 5 | Extended pathology dataset: definitions and reproducibility
ICC
Mesangial 1 Median mesangial score 0.64
Mesangial 2 % of scorable glomeruli showing severe mesangial hypercellularity (median of group) 0.54
Global GS % of total glomeruli showing global sclerosis or retracted glomerular tuft (median of group) 0.90
Normal glomeruli % of total glomeruli noted as normal (median of group) 0.27
Segmental GS % of total glomeruli showing segmental sclerosis (median of group) 0.46
Adhesion % of total glomeruli showing adhesions (median of group) 0.20
Endocapillary 1 % of total glomeruli showing segmental endocapillary hypercellularity (median of group) 0.36
Endocapillary 2 % of total glomeruli showing segmental+global endocapillary hypercellularity (median of group) 0.57
GBM duplication % of total glomeruli showing GBM duplication (median of group) 0.10
Necrosis % of total glomeruli showing necrosis (median of group) 0.31
Extracapillary 1 % of total glomeruli showing cellular crescents (median) 0.62
Extracapillary 2 % of total glomeruli showing cellular+fibrocellular crescents (median) 0.64
Extracapillary 3 Mean cellular+fibrocellular crescent score (median of group) 0.66
Extracapillary 4 % of total glomeruli showing fibrous crescents (median) 0.32
Extracapillary 5 Mean fibrous crescent score (median of group) 0.34
Tubular atrophy % of the cortex showing tubular atrophy (median of group) 0.79
Interstitial fibrosis % of the cortex showing interstitial fibrosis (median of group) 0.78
Interstitial inflammation 1 % of the cortex showing interstitial inflammation (median of group) 0.58
Interstitial inflammation 2 % of the cortex showing interstitial inflammation if majority (3 or more) checked scarred and non-scarred.
Score as 0 if majority checked scarred areas only. Scarred only 0; scarred and non-scarred 1
0.03
Arterial 1 Median arcuate artery score. Leave blank if none present 0.77
Arterial 2 Median interlobular artery score. Leave blank if none present 0.69
Arterial 3 Median artery score—worst of arcuate and interlobular arteries. Leave blank if none present. 0.69
Arteriole 1 Absent=0; present=1. Take majority verdict 0.36
Arteriole 2 Median arteriolar hyalinosis score 0.35
GBM, glomerular basement membrane; GS, glomerulosclerosis; ICC, intraclass correlation coefficient.
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as their quantification is less susceptible to error owing to a
paucity of glomeruli or because of subcapsular sampling.
Mesangial hypercellularity score
On the basis of our selection criteria, mesangial hypercellu-
larity score was included in the final schema. As reported in
the accompanying paper, the optimal cutoff given by
sensitivity analysis for predicting clinical outcome was 0.71,
which was approximated to 0.5 for clinicopathological
correlations, without a significant loss of sensitivity. Mesan-
gial score was derived from scoring each individual
glomerulus and taking the mean. Although it is reproducible,
simple to perform, and of clinical significance, for some
biopsies with large numbers of glomeruli, it can be time
consuming. We therefore reasoned that not all pathologists
would be willing or have time to score mesangial cellularity
formally in routine practice. Therefore, a simpler alternative
was tested, that is, dividing biopsies according to whether
more or less than half of the glomeruli show mesangial
hypercellularity. The relationship between this measure and
the mesangial hypercellularity score was formally assessed at
the final Oxford meeting. All pathologists were asked
independently to provide a percentage of glomeruli showing
mesangial hypercellularity for 16 cases from the study group
that did not show endocapillary or extracapillary lesions (8
with mesangial score 40.7 and 8 with mesangial score
o0.7). For all but one case with an original mesangial score
of o0.7, the majority of pathologists scored the biopsies as
o50% of glomeruli showing hypercellularity. For all cases
with an original mesangial score of 40.7, the majority of
pathologists scored the biopsies as 450% of glomeruli
showing hypercellularity. For cases near the borderline, with
an original mesangial score of 0.5–0.7, not surprisingly, there
was high interobserver variation for the cutoff of 50% of
glomeruli showing hypercellularity. On the basis of this
evaluation, it was concluded that dividing biopsies according
to whether more or less than 50% of glomeruli show
mesangial hypercellularity is a suitable alternative to the
formal mesangial hypercellularity score for use in everyday
practice. However, for research studies and clinical trials,
formal mesangial hypercellularity scores are recommended.
Pathology variables assessed in the final classification
As described above, the initial pathology variables were
refined by excluding those with poor interobserver reprodu-
cibility and only including one variable from those pairs or
groups that were shown to be strongly correlated. This left
the following variables, all common in IgA nephropathy, to
be further analyzed in relation to the clinical data:
(1) mesangial cellularity score;
(2) percentage of glomeruli showing segmental adhesions or
sclerosis;
(3) percentage of glomeruli showing endocapillary hypercel-
lularity;
(4) percentage of glomeruli showing cellular or fibrocellular
crescents;
(5) percentage of interstitial fibrosis/tubular atrophy; and
(6) arterial score
The accompanying paper describes the further analysis of these
variables in relation to clinical presentation and outcome.
Adequacy of biopsies for classification
The minimum number of glomeruli for a biopsy to be
included in the study was initially set at eight. The median
number of glomeruli in the 265 biopsies meeting inclusion
Table 6 | Correlations between pathology variables
Mesang GS Endocap Extracap Interstitium Vessels
Mes1 Mes2 GlobGS SegGS Adh End1 End2 GBMdup Necr Extr1 Extr2 Extr3 Extr4 Extr5 TubAt IntFib IntInfl1 IntInfl2 Art1 Art2 Art3 Artiol1 Artiol2
Mes1 — 0.7 0.2 0.3 0.3 0.3 0.2 0.2 0.2 0.3
Mes2 — 0.3 0.3 0.3
GlobGS — 0.4 0.2 0.7 0.8 0.6 0.3 0.3 0.4 0.3
SegGS — 0.5 0.4 0.4 0.3 0.3 0.5 0.5 0.4
Adh — 0.3 0.3 0.2 0.2 0.3 0.3 0.3
End1 — 0.99 0.3 0.4 0.5 0.5
End2 — 0.3 0.4 0.5 0.5
GBMdup —
Necr —
Extr1 — 0.7 0.7
Extr2 — 0.99 0.4 0.4
Extr3 — 0.4 0.4 0.2
Extr4 — 0.99
Extr5 —
TubAt — 0.98 0.9 0.8 0.3 0.3 0.4 0.4
IntFib — 0.9 0.8 0.3 0.3 0.4 0.4
IntInfl1 — 0.3
IntInfl2 —
Art1 — 0.8 0.9 0.6
Art2 — 0.9 0.5 0.5
Art3 — 0.5 0.5
Artiol1 — 0.95
Artiol2 —
Adh, adhesion; Art, arterial; Artiol, arteriole; End, endocapillary; Extr, extracapillary; GBMdup, glomerular basement membrane duplication; GlobGS, global glomerulosclerosis;
IntFib, interstitial fibrosis; IntInfl, interstitial inflammation; Mes, mesangial; Necr, necrosis; SegGS, segmental glomerulosclerosis; TubAt, tubular atrophy.
Only statistically significant R values (correlation coefficients) are shown.
Statistically significant correlations were determined using the Holm–Bonferroni method to minimize the probability of making a Type I statistical error.
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criteria was 18. To determine whether the number of
glomeruli in a biopsy influences the histological scores, the
glomerular number was correlated with scores for the 25
histological lesions. There was no significant correlation,
other than with endocapillary and extracapillary prolifera-
tion. These showed a weak positive correlation with the
number of glomeruli in a biopsy. For endocapillary 2 versus
number of glomeruli, Spearman’s correlation coefficient was
0.22 (Pp0.001), and for extracapillary 2 versus number of
glomeruli, Spearman’s correlation coefficient was 0.15
(P¼ 0.014).
To better illustrate these findings, the biopsies were then
divided into three groups according to the number of
glomeruli: 8–12 (n¼ 69), 13–17 (n¼ 59), andX18 glomeruli
(n¼ 137). Scores for the 25 histological lesions were
compared between these groups. There was no significant
difference in the mean score for any lesion between the
biopsies with 8–12 and 13–17 glomeruli. Biopsies with X18
glomeruli showed marginally but statistically significant
higher mean scores for only three lesions: mesangial 2
(8.1±13.4 versus 5.7±13.2 for 8–12 glomeruli, and
6.0±13.4 for 13–17 glomeruli, P¼ 0.01), endocapillary 1
(6.3±8.9 versus 5.3±11.8 for 8–12 glomeruli, and 5.3±10.3
for 13–17 glomeruli, P¼ 0.01), and endocapillary 2
(7.9±13.1 versus 6.5±5.1 for 8–12 glomeruli and
5.9±12.2 for 13–17 glomeruli, P¼ 0.006).
DISCUSSION
Our aim was to design a systematic approach for the
development of a reproducible pathological classification of
IgA nephropathy that would predict clinical outcome. To this
end, we collected cases with defined clinical outcomes and
assessed a range of features in the renal biopsies. We
proceeded by first assessing the reproducibility of the scoring
of individual biopsy features, then asking which features
showed good reproducibility and were independent, and
finally asking which of those were related to presenting
clinical parameters and had an independent relevance to
clinical outcome. Although this seems to be a logical way to
develop a classification, this approach has not generally been
followed in renal pathology. Thus, the classification schemes
for lupus nephritis, as first defined in the World Health
Organization (WHO) classifications and subsequently in the
International Society of Nephrology/Renal Pathology Society
(ISN/RPS) classification,18 were developed by groups of
experts without any attempt to show that the definitions or
the classes were reproducible entities. Subsequent testing has
shown areas of high interobserver variation, with k-scores
o0.4 for differentiating active from chronic and segmental
from global in class IV disease.19 In addition, the classifica-
tions were not tested for their predictive value before
publication, although this has been done subsequently.20,21
With regard to earlier classification schemes in IgA nephro-
pathy, several of these have been tested for their predictive
value, but, in many cases, the variables used in the
classifications were not systematically defined, and in no
case was there an attempt to examine the reproducibility of
the histological variables that were assessed. For example, in
the Lee classification,22 the vague terminology used (terms
such as mostly, occasional, frequent, and localized) makes the
schema difficult to be employed in a reproducible way.
Consequently, earlier histological classifications of IgA
nephropathy have not been accepted by the majority of
nephropathologists. In a 2006 Renal Pathology Society
survey, only 37% of responding pathologists used a
classification system for reporting IgA nephropathy biopsies.
Five different schema were used, of which that of Haas23 was
the most popular, but even this was used by only 14% of
pathologists (38% of those who used a classification system).
The range of histological features we studied was restricted
to those that can be assessed by light microscopy, and all the
included features had been suggested by earlier studies to
have an effect on outcome. Our initial definitions followed
those used earlier in the WHO atlas of glomerular diseases24
and in the classification of lupus nephritis.18 Although the
definitions seemed straightforward and well established, it is
important to recognize that some have not been easy to apply
in practice. Perhaps the most critical of these was the
definition of mesangial hypercellularity, which is a typical
feature in IgA nephropathy. Our scoring system depended on
assessing the number of nuclei in glomerular mesangial areas,
but it became clear at the second meeting of pathologists that
there was uncertainty about what constituted a mesangial
area; hence, a revision of the definition was necessary. A
problem was also encountered with the definition of necrosis,
which needed to be revised as shown in Table 2. Cellular
crescents are most commonly defined as extracapillary
proliferation involving at least 25% of the glomerular
circumference. We also noted smaller foci of extracapillary
proliferation (10–25 and o10% of the glomerular circum-
ference) in our biopsies, and sought to determine whether
the size, rather than merely the extent, of crescents was of
independent significance. The correlation between the
percentage of glomeruli with crescents and the crescent score
(that included a multiplier for size of the individual
crescentic lesions) was very close indeed, r¼ 0.99, indicating
that subdividing crescents by size provided no additional
information.
For each of the variables scored, we assessed the ICC. It is
notable that some features in which the definitions seemed
simple were poorly reproducible, for example, glomerular
basement membrane duplication, fibrous crescents, and
arteriolar hyaline. We have not further examined why there
is such poor agreement on these features. One limitation of
our study is that, in order to ensure consistency across
pathologists, we restricted the scoring to a single PAS-stained
section. Although we believe that most of the features
examined would be seen well in PAS-stained sections, this
might explain the variability of glomerular basement
membrane duplication that is more reliably assessed in silver
stains. We also found that necrosis could not be reliably
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assessed on the PAS stain. It is also of note that
reproducibility of the percentage of ‘normal’ glomeruli was
poor. This may not be surprising when one considers the
nature of IgA nephropathy. Unlike pauci-immune vasculitic
glomerulonephritis, in which lesions are truly focal and
segmental, all glomeruli in IgA nephropathy are abnormal to
some extent, in that all contain mesangial IgA deposits. The
most minor changes are detectable only on immunostaining
or on electron microscopy, but large deposits may be seen on
PAS stain, even in the absence of proliferation, and a subtle
increase in mesangial matrix frequently accompanies the
deposits. It is likely that the difference between pathologists
in identifying these very mild changes at light microscopy
explains the poor ICC for ‘normal’ glomeruli.
It could be argued that the good interobserver reprodu-
cibility we have achieved for some variables reflects the fact
that the scoring was carried out by a group of pathologists
who had met together on several occasions and that such
good reproducibility may not translate into clinical patho-
logy practice. Although this may be true, we feel that it is
important that we have shown that the features retained in the
classification had good reproducibility and, when several
different features were strongly correlated, we used the
one feature easiest to identify and least susceptible to sampling
error.
An important question for many renal diseases is the issue
of how much tissue is required for reliable diagnosis and
classification. The answer depends, to a certain extent, on the
nature of the condition. In general, diffuse glomerular
diseases will require fewer glomeruli than those in which
the pathology is focal. In the case of IgA nephropathy,
glomerular IgA deposits are diffuse and a biopsy containing a
single glomerulus may be sufficient to make a firm diagnosis.
Many of the glomerular lesions, however, are focal, including
endocapillary and extracapillary proliferation and segmental
sclerosis. Thus, to apply a classification that includes
quantitation of these lesions will require more than one
glomerulus. We initially set the minimum number of
glomeruli for inclusion in the study at eight. This limit was
chosen, as it had been used in earlier studies of IgA
nephropathy2 and was similar to the criterion used in other
conditions, such as the Banff classification of allograft
pathology (8 glomeruli) and the ISN/RPS classification of
lupus nephritis (10 glomeruli). We subsequently analyzed the
histological scores according to biopsy size, in order to test
the validity of using eight glomeruli as a criterion for
adequacy. It is not surprising that some of the focal lesions
(endocapillary and extracapillary proliferation scores)
showed a weak correlation with the number of glomeruli.
This is unlikely to be clinically relevant; those biopsies with
the fewest glomeruli (8–12) showed no difference in mean
scores compared with those with 13–17 glomeruli. Although
those biopsies containing numbers of glomeruli above the
median for the whole group (18) had significantly more
severe mesangial and endocapillary lesions than those below
the median, it would be impractical to exclude 50% of
biopsies from classification on the basis of a minor difference
in some focal lesions.
The statistical methodology used to develop this classifi-
cation merits clarification. We used the ICC to address the
reliability of multiple raters. This flexible method is an
extension of the commonly used k-statistic that is used to
assess the agreement between two diagnostic tests, but
applied to 42 raters and/or ordinal or continuous measure-
ments.25 Perfect agreement is indicated by an ICC of 1, and
pure chance is indicated by a score of 0. The interpretation of
the coefficient levels can be subjective, but authors have
suggested a minimum of 0.4 as being necessary to define fair
agreement.26,27
Given the number of variables studied and the exploratory
nature of the work, numerous statistical tests were carried
out, but appropriate precautions were taken to minimize type
1 error, that is, falsely rejecting the null hypothesis and
assuming statistically significant differences between two
variables. This was addressed using the Holm–Bonferroni
method for multiple comparisons,28,29 a valid modification
of the more stringent Bonferroni correction.30
In summary, we have described here a systematic
approach to developing a histological scoring scheme in
IgA nephropathy. The results that we have found for
interobserver reproducibility for individual features are likely
to be applicable to other types of glomerulonephritis, but it
should not be assumed that this will be true for the
correlations between variables that may depend on the
underlying pathobiology of each glomerular disease. We
believe that our approach can act as a model for developing
classifications for other types of renal disease. The accom-
panying paper describes the way in which the histological
features described here relate to clinical outcome.
MATERIALS AND METHODS
The overall design of the study, patient cohort, clinical data set,
and clinicopathological correlations are described in the accom-
panying paper. Briefly, clinical data and renal biopsy material from
265 patients with IgA nephropathy were collected from 8 countries
from 4 continents. Five centers from Asia, six from Europe, two
from the United States, one from South America, and two
multicenter networks (Canada and the United States) participated.
Biopsies containing o8 glomeruli were regarded as inadequate
for scoring and were excluded from the analysis.
Statistical methods
We assessed reproducibility for each variable of the extended
pathology data set using ICC.31 The ICC is a measure of
reproducibility applicable to multiple raters. By convention, ICC
of o0.40 is poor inter-rater reliability, 0.40–0.59 is moderate,
0.60–0.79 is substantial, and 0.80 is outstanding.32,33
Correlations between pathology variables were carried out using
the Pearson test or the Spearman test appropriately. Given the
number of possible comparisons between pathology variables, we
used the Holm–Bonferroni method to minimize the risk of making a
type 1 statistical error.28,29 Briefly, this methodology compares the
smallest P-value of all (k) comparisons with an a-value of 0.05/k. If
that P-value is o0.05/k, the association is considered to be
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statistically significant (reject the null hypothesis). The next smallest
P-value is then compared with 0.05/(k1), the following with 0.05/
(k2), etc. This continues until a P-value is superior to the
calculated a-value, at which point, the procedure is stopped and all
remaining comparisons are considered not statistically different
(accept all other null hypotheses).
Analyses were carried out using SPSS software (version 11, SPSS.
Chicago IL, USA).
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